Retisert Bausch & Lomb/control delivery systems

Lyndell L. Lim, Justine R. Smith, James T. Rosenbaum

Research output: Contribution to journalReview article

19 Scopus citations

Abstract

Retisert (Envision TD), a sustained release intraocular implant containing fluocinolone acetonide, has been developed and launched in the US by Bausch & Lomb and Control Delivery Systems for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye.

Original languageEnglish (US)
Pages (from-to)1159-1167
Number of pages9
JournalCurrent Opinion in Investigational Drugs
Volume6
Issue number11
StatePublished - Nov 1 2005

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Fingerprint Dive into the research topics of 'Retisert Bausch & Lomb/control delivery systems'. Together they form a unique fingerprint.

  • Cite this